Kuva Labs, Inc Press Releases - EIN Presswire - Press Release Distribution Service

Published on August 21, 2026 - 09:58 GMT

Kuva intends to provide new fully funded offer to Lisata Therapeutics

HOUSTON, TX, UNITED STATES, August 21, 2026 /⁨EINPresswire.com⁩/ -- Kuva Labs, Inc. ("Kuva"), a clinical-stage oncology company, today announced its intention to submit a new fully funded offer to the Board of Directors of Lisata Therapeutics, …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on July 24, 2026 - 13:00 GMT

Kuva Labs Inc. Announces Termination of Lisata Therapeutics, Inc. Tender Offer

HOUSTON, TX, UNITED STATES, July 24, 2026 /⁨EINPresswire.com⁩/ -- Houston, TX (July 24, 2026) – Kuva Labs Inc. (“Kuva”) today announced that it and its wholly owned subsidiary, Kuva Acquisition Corp. (the “Purchaser”), were not able to complete the …

Distribution channels: Business & Economy ...

Published on June 1, 2026 - 12:00 GMT

Kuva and Lisata Therapeutics Tender Offer Update

HOUSTON, TX, UNITED STATES, June 1, 2026 /⁨EINPresswire.com⁩/ -- As previously announced on May 29, 2026, Kuva Labs, Inc. (“Kuva” or “Parent”) and Lisata Therapeutics, Inc. (“Lisata”) (Nasdaq: LSTA), together with Kuva’s wholly owned subsidiary Kuva …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on May 29, 2026 - 21:23 GMT

Kuva and Lisata Therapeutics Amend Merger Agreement

HOUSTON, TX, UNITED STATES, May 29, 2026 /⁨EINPresswire.com⁩/ -- On May 29, 2026, Kuva Labs, Inc. (“Kuva” or “Parent”) and Lisata Therapeutics, Inc. (“Lisata”) (Nasdaq: LSTA), together with Kuva’s wholly owned subsidiary Kuva Acquisition Corp. (“Kuva …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on May 4, 2026 - 12:36 GMT

Kuva Intends to Commence Tender Offer for Lisata Therapeutics by May 29, 2026

Kuva reaffirms commitment to previously announced acquisition terms HOUSTON, TX, UNITED STATES, May 4, 2026 /⁨EINPresswire.com⁩/ -- On May 3, 2026, Kuva Labs, Inc. (“Kuva” or “Parent”) and Lisata Therapeutics, Inc. (“Lisata”) (Nasdaq:LSTA), together with …

Distribution channels: Business & Economy, Companies ...